Literature DB >> 32106816

High-dose nitrate therapy recovers the expression of subtypes α1 and β-adrenoceptors and Ang II receptors of the renal cortex in rats with myocardial infarction-induced heart failures.

Yubo Peng1, Yanfang Li2, Mengmeng Chen3, Junying Song4, Zhili Jiang5, Shutian Shi5.   

Abstract

BACKGROUND: Few studies examined the effect of long-acting nitrates on renal function in chronic heart failure (CHF). Thus, we aimed to investigate the effect of long-acting nitrate on the expression of adrenoceptors (AR) and angiotensin II receptor (ATR) subtypes of the renal cortex, in rats with myocardial infarction-induced CHF.
METHODS: Rats were randomly divided into the following groups: control, sham-operated, CHF, low- and high-dose nitrate, positive drug control (olmesartan), and high-dose of long-acting nitrate + olmesartan. Ultrasound echocardiography markers were compared, and the levels of AR subtypes, AT1R, and AT2R were measured using reverse transcription-polymerase chain reaction and western blot analysis. Histopathology of the kidney was determined on hematoxylin and eosin-stained sections.
RESULTS: CHF significantly increased plasma renin activity (PRA) and angiotensin II levels, upregulated AT1R expression and downregulated α1A-, β1-, β2-AR, and AT2R expression compared to the sham control. High-dose nitrate or olmesartan alone, and especially in combination, decreased the levels of PRA and angiotensin II and downregulated the CHF-induced expression of AT1R, α1A-, β1-, and β2-AR, and AT2R. CHF resulted in significant impairment of the renal tissue, including inflammatory cells infiltration to the tubular interstitium and surrounding the renal glomerulus, and tubular necrosis, which was alleviated in all treatment groups to different degrees.
CONCLUSIONS: Long-acting nitrates could reverse CHF-induced changes in AR and ATR subtypes in the kidney, and improve cardiac function to protect renal function. Compared with monotherapy, the combination of nitrates and olmesartan shows more significant benefits in regulating AR and ATR subtypes.

Entities:  

Keywords:  Adrenoceptors; Ang II receptors; Chronic heart failure; Long-acting nitrate; Renal function

Year:  2020        PMID: 32106816     DOI: 10.1186/s12872-020-01353-z

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  3 in total

1.  Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation.

Authors:  Yun Cai; Beijian Zhang; Adilan Shalamu; Tingwen Gao; Junbo Ge
Journal:  Ann Transl Med       Date:  2022-06

2.  Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats.

Authors:  Jinshuang Li; Hao Ding; Yong Li; Hao Zhou; Wanhong Wang; Yong Mei; Ronglin Zhang
Journal:  Amino Acids       Date:  2021-06-05       Impact factor: 3.520

3.  Peripheral chemoreflex modulation of renal hemodynamics and renal tissue PO2 in chronic heart failure with reduced ejection fraction.

Authors:  Kiefer W Kious; Andrew Philipose; Luke J Smith; Jayson P Kemble; Stephanie C E Twohey; Kalie Savage; Hugo S Díaz; Rodrigo Del Rio; Noah J Marcus
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.